Navigation Links
GORE-TEX Bifurcated Stretch Vascular Grafts

ProductsGORE-TEX Bifurcated Stretch Vascular Grafts
Company W. L. Gore & Associates, Inc.
Item GORE-TEX Bifurcated Stretch Vascular Grafts
Features 
  • Kink resistance in area of angulation
  • Improved handling, soft and supple
  • Conformability at the anastomosis
  • Forgiveness in length matching
  • The security of reinforced GORE-TEX Vascular Grafts
    • Description GORE-TEX Stretch Vascular Grafts have met the challenges of the most demanding vascular procedures. Recognized for exceptional performance and quality, they have earned the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and ensure utmost thrombectomy safety. The GORE-TEX Stretch Vascular Graft, with published improved patency for dialysis access (10 papers 650 patients and 1 abstract), is available in a wide range of configurations, including straight, tapered, removable ringed and bifurcated.
    Info W. L. Gore & Associates, Inc.
    Customer Service: (800) 437-8181
    Web site: http://www.goremedical.com/

    Related medicine products :

    1. GORE-TEX INTERING Vascular Graft-Peripheral Thin Walled Stretch
    2. GORE-TEX INTERING Vascular Graft-Standard Walled Stretch
    3. GORE-TEX® INTERING Vascular Graft-Standard Walled
    4. GORE-TEX® Vascular Grafts
    5. GORE-TEX INTERING Vascular Graft-Revision Stretch
    6. GORE-TEX Vascular Grafts-Ringed
    7. GORE-TEX Bifurcated Vascular Grafts
    8. GORE-TEX Stretch Vascular Grafts
    9. GORE-TEX Stretch Vascular Grafts-Ringed
    10. GORE-TEX Stretch Vascular Grafts-Standard Wall
    11. GORE-TEX Vascular Grafts configured for Pediatric Shunts
    Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10BioCryst Provides Update Regarding Peramivir for Influenza 5116 1BioCryst Provides Update Regarding Peramivir for Influenza 5116 2BioCryst Provides Update Regarding Peramivir for Influenza 5116 3BioCryst Provides Update Regarding Peramivir for Influenza 5116 4BioCryst Provides Update Regarding Peramivir for Influenza 5116 5Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2